DFH Therapeutics and HHS describe betulinic acid derivatives for HIV infection Jan. 22, 2020 No Comments
CAPELLA trial recruits patients with HIV to evaluate add-on lenacapavir treatment Dec. 24, 2019 No Comments
Gilead evaluates GS-6207 with other antiretrovirals for HIV in new phase II study Dec. 24, 2019 No Comments
FDA issues complete response letter for long-acting cabotegravir/rilpivirine regimen for HIV Dec. 23, 2019 No Comments
RSS